0

IM-54

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP861891501
CAS861891-50-1
MDL NumberMFCD18382109
Molecular Weight325.40
InChI KeySGLOMINNEBLJFF-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: 5 mg/mL (clear solution)
Assay≥98% (HPLC)
Colorlight orange to dark orange
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

Clinical, Radiological and Electrophysiological Comparison of Immunomodulatory Therapies in Multiple Sclerosis

Gençer Genç, Şeref Demirkaya, Semai Bek, Zeki Odabaşi

Noro Psikiyatr Ars. 2017 Jun;54(2):116-124.

PMID: 28680308

1

Development of Selective Inhibitors of Necrosis

Mikiko Sodeoka, Kosuke Dodo

Chem Rec. 2010 Oct;10(5):308-14.

PMID: 20848666

1

Indolylmaleimide Derivative IM-17 Shows Cardioprotective Effects in Ischemia-Reperfusion Injury

Kosuke Dodo, Tadashi Shimizu, Jun Sasamori, Kazuyuki Aihara, Naoki Terayama, Shuhei Nakao, Katsuya Iuchi, Masahiro Takahashi, Mikiko Sodeoka

ACS Med Chem Lett. 2018 Jan 29;9(3):182-187.

PMID: 29541357

1

Inhibition of Hydrogen Peroxide-Induced Necrotic Cell Death With 3-amino-2-indolylmaleimide Derivatives

Kosuke Dodo, Miho Katoh, Tadashi Shimizu, Masahiro Takahashi, Mikiko Sodeoka

Bioorg Med Chem Lett. 2005 Jun 15;15(12):3114-8.

PMID: 15878276

1

Structure-Activity Relationship Study of 3-Amino-2-indolyllactam Derivatives: Development of Inhibitors of Oxidative Stress-Induced Necrosis

Kosuke Dodo, Kenji Hayamizu, Tadashi Shimizu, Mikiko Sodeoka

Chem Pharm Bull (Tokyo). 2016;64(7):886-98.

PMID: 27373644

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode